- Recent Funding
- Founders
- Daniel Nadler
About Daniel
Daniel Nadler is the founder of OpenEvidence, an AI platform designed to assist healthcare professionals by providing access to medical information. The platform helps doctors search medical literature and review cited information relevant to clinical questions. Nadler previously founded Kensho and co-founded EDO. He holds a Ph.D. from Harvard University.
Daniel Nadler | From Kensho to OpenEvidence, AI in Healthcare
Every tag links its source.
Network
Background
1
- Role CEO of OpenEvidence
N
Timeline, line by line 7
In their words
1
- “Access to medical knowledge shouldn’t depend on geography.”Regarding the expansion of OpenEvidence to low- and middle-income countries. · Sep 23, 2026
T
Interviews and coverage
7
- Fresh NPJ Health Systems study confirms the reliability of Daniel Nadler’s OpenEvidenceDigital Journal · Oct 6, 2026
D - OpenEvidence is free for now. Its CEO has a plan for who will pay.NBC News · May 13, 2026
N - AI Founder Daniel Nadler Is Twice As Rich After OpenEvidence Hits $12 Billion ValuationForbes · Jan 21, 2026F
- A visit to your doctor will soon look very different thanks to Daniel Nadler’s OpenEvidenceSan Francisco Examiner · Aug 19, 2026
S - How OpenEvidence Is Helping DoctorsUSA Today · Aug 28, 2026
U - Anthropic, OpenEvidence Expand Free AI Clinical Tool to 100 Countries: ReportTradingView · Sep 23, 2026
T - Cochrane evidence to inform OpenEvidence usersCochrane.org · Mar 3, 2026
C
How this is researched
Researched from public pages: press, interviews, the company's site and the founder's own posts. Each source logo links the page that states the row; anything we couldn't source is left out. The archetype is our reading of that record, from a fixed set so founders can be compared. Updated Oct 12, 2026.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy